Longboard Pharmaceuticals - Ownership and Business Overview

Life ScienceCompany

Longboard Pharmaceuticals Ownership

Who owns Longboard Pharmaceuticals?

Longboard Pharmaceuticals is owned by H. Lundbeck A/S. It was acquired on October 14, 2024.

Was Longboard Pharmaceuticals formerly PE-backed?

Yes. Longboard Pharmaceuticals was formerly owned by 1 private investor.

Longboard Pharmaceuticals Business Overview

Where is Longboard Pharmaceuticals headquartered?

Longboard Pharmaceuticals is headquartered in La Jolla, California.

What is Longboard Pharmaceuticals’ revenue?

Longboard Pharmaceuticals disclosed revenue of 57M USD for 2023 and 45M USD for 2022.

What sector is Longboard Pharmaceuticals in?

Longboard Pharmaceuticals is a life science company.

When was Longboard Pharmaceuticals founded?

Longboard Pharmaceuticals was founded in 2020.

Life Science M&A Summary in 2024

Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2024. The largest life science acquisition in 2024 was Catalent - which was acquired by Novo Holdings A/S for $16.5B.

Join Mergr to view all 186 acquisitions of life science companies in 2024, including 14 acquisitions by private equity firms, and 172 by strategics.

Longboard Pharmaceuticals

Longboard Pharmaceuticals, Inc.

4275 Executive Square, Suite 950,
La Jolla, California La Jolla
United States,
(858) 789-9283
www.longboardpharma.com

Longboard Pharmaceuticals is a clinical-stage biopharmaceutical company, focuses on developing medicines for neurological diseases. Its products include LP352, a Phase I clinical trial product for the developmental and epileptic encephalopathies (DEEs) and refractory epilepsies; LP143, a product for amyotrophic lateral sclerosis and other neuroinflammatory disorders; and LP659, a product for multiple neuroinflammatory disorders. Longboard Pharmaceuticals was founded in 2020 and is based in La Jolla, California.


 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.